Keywords: توسعه دارویی; TB; tuberculosis; MTB; Mycobacterium tuberculosis; MDR-TB; multi-drug resistant tuberculosis; XDR-TB; extensively drug resistant tuberculosis; TDR-TB; totally drug resistant tuberculosis; INH; isoniazid; WHO; World Health Organization; RIF; rifampicin; PZ
مقالات ISI توسعه دارویی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: توسعه دارویی; Clinical pharmacology; Drug development; Modelling; Pharmacokinetics; Pharmacodynamics;
Keywords: توسعه دارویی; Trypanosomiasis; Tubulin inhibitor; Selective index; Drug development;
Keywords: توسعه دارویی; Open innovation; Data sharing; Pharmacometric models; Modelling workflows; Drug development;
Keywords: توسعه دارویی; Human metabolism; Genome-scale metabolic model; Constraint-based analysis; Topological analysis; Drug development;
Keywords: توسعه دارویی; Acute heart failure syndromes; Acute heart failure therapy; Clinical trials; Drug development; Pharmacology;
Keywords: توسعه دارویی; Substituent effect descriptor; Hammett constant; Biological activity; Proton affinity; Drug development;
Keywords: توسعه دارویی; cardiovascular disease; cardiovascular therapeutics; drug development; drug discovery; innovation; quantitative modeling;
Keywords: توسعه دارویی; Amorphous; Critical micelle concentration; Crystalline; Drug development; Photooxidation; Stability; Surface activity;
Keywords: توسعه دارویی; Drug development; Precision medicine; Phase III trials; Biomarker; FDA;
Keywords: توسعه دارویی; Antioxidants; Pharmacokinetic analysis; Dopamine; Drug development; Oxidative stress; MPTP;
Keywords: توسعه دارویی; Alkaloids; Tuberculosis; Mycobacterium tuberculosis; Antimycobacterial agents; Multi drug resistant tuberculosis; Natural products; Drug development;
Keywords: توسعه دارویی; 3-BC; 3-benzylidene camphor; 4-MBC; 4-methylbenzylidene camphor; Aβ; amyloid-β; ABAD; Aβ-binding alcohol dehydrogenase; AD; Alzheimer's disease; AI; aromatase inhibitor; AKR; aldo-keto reductase; AME; apparent mineralocorticoid excess; AR; androgen r
Keywords: توسعه دارویی; Ornithine carbamoyltransferase; Drug-induced liver injury; Biomarker; Hepatocytes; Mitochondria; Drug development; Toxicity; Liver;
Keywords: توسعه دارویی; Inborn errors; Neurocognitive; Clinical outcome assessment; Natural history studies; Rare diseases; Drug development;
Keywords: توسعه دارویی; RPPA; Proteomics; Biomarker; Drug development; Pharmacodynamic;
Keywords: توسعه دارویی; Atrial fibrillation; Pathophysiology; Treatments; Ablation; Drug development;
Keywords: توسعه دارویی; Personalised oncology; Therapeutics; Biomarkers; Cancer drivers; Drug development; Proteomics;
Keywords: توسعه دارویی; Aging; Aldosterone; Hearing loss; Startle reflex; Drug development;
Keywords: توسعه دارویی; Epilepsy; Antiepileptic drugs; Drug development; Clinical trials;
Keywords: توسعه دارویی; Alzheimer's disease; Reproducibility; Animal models; Preclinical; Drug development;
Keywords: توسعه دارویی; Aerosol; Drug delivery; Drug development; Extruder; Nebulizer
Keywords: توسعه دارویی; decision making; drug development; methodology; patient-centered;
Keywords: توسعه دارویی; Malaria; Plasmodium falciparum; Pyrimidine biosynthetic pathway; Drug target; Drug development; Chemotherapy
Keywords: توسعه دارویی; Nuclear magnetic resonance spectroscopy; Drug development; Cardiac troponin activator; Calcium sensitizer; Systolic heart failure;
Keywords: توسعه دارویی; Alzheimer's disease; Drug development; Phase I; Phase II; Phase III; Biomarkers; Amyloid; Tau; Cognitive enhancement;
Keywords: توسعه دارویی; designer natriuretic peptide; drug development; heart failure; hypertension; natriuretic peptide; ANP; A-type natriuretic peptide; AS-BNP; alternatively spliced variant of BNP; BNP; B-type natriuretic peptide; BP; blood pressure; CD-NP; cenderitide; cGMP;
Keywords: توسعه دارویی; Pharmacokinetics; Pharmacodynamics; Animal model; Drug development;
Keywords: توسعه دارویی; Nucleoside analog; Lipid conjugate; Drug development; Liposomes;
Keywords: توسعه دارویی; Polo-like kinase; Acute myeloid leukemia; Myelodysplastic syndromes; Drug development;
Keywords: توسعه دارویی; Patent indicators; Patent system; Product commercialization; Pharmaceutical industry; Drug development;
Keywords: توسعه دارویی; Onchocerciasis; Elimination; Africa; Discovery; Drug development; Implementation research;
Keywords: توسعه دارویی; amyotrophic lateral sclerosis (ALS); neurodegeneration; motor neuron diseases; drug development; genomics
Keywords: توسعه دارویی; cancer therapy; checkpoint inhibitors; drug development; immunotherapy; lung cancer; next-generation sequencing; precision oncology; targeted therapy;
Keywords: توسعه دارویی; Allopregnanolone (PubChem CID: 16219900); Brivaracetam (PubChem CID: 9837243); Ganaxolone (PubChem CID: 6918305); Selurampanel (PubChem CID: 45381907); Cenobamate (PubChem CID: 11962412); VX-765 (PubChem CID: 53245642); Biperiden (PubChem CID: 2381); Bume
Keywords: توسعه دارویی; Pulmonary arterial hypertension; Serotonin; Statins; Vasoactive intestinal polypeptide; Imatinib; Drug development;
Keywords: توسعه دارویی; Indigenous knowledge; Medicinal plants; Quantitative ethnobotany; Cultural erosion; Drug development; Pakistan;
Keywords: توسعه دارویی; Cancer; Solid tumors; Metastasis; Inhibitors; Drug development;
Keywords: توسعه دارویی; DPI; dry powder inhaler; eNPV; expected net present value; LAMA; long-acting muscarinic antagonist; LABA; long-acting β-agonist; NPV; net present value; pMDI; pressurized metered-dose inhaler; COPD; chronic obstructive pulmonary disease; Estimated net pr
Keywords: توسعه دارویی; Drug development; Drug repositioning; Anti-tumor drug; Alpha-1 adrenoceptor blocker; Apoptosis
Keywords: توسعه دارویی; Personalized medicine; Targeted therapy; Drug development;
Keywords: توسعه دارویی; Contact sensitizer; Occupational contact dermatitis; Classification; Occupational health; Worker safety; Pharmaceutical manufacturing; Drug development; Drug research; Quantitative risk assessment;
Keywords: توسعه دارویی; Monoclonal antibodies; Drug development; Network biology; Transcriptomics; Proteomics; Systems biology
Keywords: توسعه دارویی; drug development; pregnancy; children; drug trials
Keywords: توسعه دارویی; Glucocorticoids; Nongenomic mechanism; Drug development; Side effects; Anti-inflammation; Clinical usage
Keywords: توسعه دارویی; ECM; extracellular matrix; PAD; peripheral arterial disease; PD; pharmacodynamics; PK; pharmacokinetics; VEGF; vascular endothelial growth factor; Mechanistic computational model; Systems pharmacology; Drug development; Pharmacokinetics; Pharmacodynamics;
Keywords: توسعه دارویی; Botanical; Regulation; Investigational New Drug; IND; New Drug Application; NDA; New drug approval; Drug development; Food and Drug Administration
Keywords: توسعه دارویی; Inflammatory bowel disease; Crohn's disease; Ulcerative colitis; Drug development; Clinical trialsCD, Crohn's disease; CDAI, Crohn's Disease Activity Index; CRP, C-reactive protein; Fab, Fragment antigen-binding; GM-CSF, Granulocyte-Macrophage Colony-Stim
Keywords: توسعه دارویی; Drug development; Paediatric oncology; Regulatory framework; Paediatric Investigation Plan; Precompetitive development; Long-term follow up;
Keywords: توسعه دارویی; Collaborative networks; Drug development; Molecular screening platforms; Translational oncology;